Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Citi
US Army
Daiichi Sankyo
Argus Health
Mallinckrodt
Chinese Patent Office
AstraZeneca
Moodys

Generated: April 27, 2018

DrugPatentWatch Database Preview

CONRAY 43 Drug Profile

« Back to Dashboard

Which patents cover Conray 43, and what generic alternatives are available?

Conray 43 is a drug marketed by Liebel-flarsheim and is included in one NDA.

The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
Drug patent expirations by year for CONRAY 43
Pharmacology for CONRAY 43
Medical Subject Heading (MeSH) Categories for CONRAY 43
Synonyms for CONRAY 43
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt)
13087-53-1
16240-57-6
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid,6-
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; 6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;6-(methylamino)hexane-1,2,3,4,5-pentol
519-25-5
AC1L19JR
AC1LCVC4
AN-18407
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
CA003316
CHEBI:31714
CHEMBL1201125
Conray (TN)
Conray 280
Conray 30
Conray 60
Conray meglumin
Conray meglumine 282
Contrix 28
Cysto-Conray
D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo- 5-[(methylamino)carbonyl]benzoate (salt)
D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)
D01999
DTXSID90199856
EINECS 235-998-9
Iotalamate de methylglucamine
Iotalamate de methylglucamine [French]
Iotalamic acid meglumine salt
Iothalamate meglumine
Iothalamate meglumine (USP)
Iothalamate Meglumine [USAN]
Iothalamate meglumine [USP]
IOTHALAMATE MEGLUMINE; MEGLUMINE
Iothalamate methylglucamine
Iothalamate methylglucamine salt
Iothalamic acid N-methylgucamine salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Jotalamsaeure methylglucaminesalz
Jotalamsaeure methylglucaminesalz [German]
LS-85183
Meglumine conray
Meglumine iotalamate
Meglumine Iotalamate Injection
Meglumine iotalamate injection (JP17)
Meglumine iothalamate
Meglumine Iothalamate (BAN)
Meglumine Iothalamate [BAN]
Meglumine isothalamate
Methylglucamine iotalamate
Methylglucamine iothalamate
SCHEMBL180546
UNII-XUW72GOP7W
XUW72GOP7W

US Patents and Regulatory Information for CONRAY 43

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim CONRAY 43 iothalamate meglumine INJECTABLE;INJECTION 013295-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Mallinckrodt
Federal Trade Commission
Queensland Health
Dow
Cerilliant
Chubb
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.